Skip to Content

Fidelity® Select Pharmaceuticals Port FPHAX

Medalist Rating as of | See Fidelity Investment Hub
  • NAV / 1-Day Return 23.07  /  0.35 %
  • Total Assets 819.5 Mil
  • Adj. Expense Ratio
    0.760%
  • Expense Ratio 0.760%
  • Distribution Fee Level Low
  • Share Class Type No Load
  • Category Health
  • Investment Style Large Growth
  • Min. Initial Investment
  • Status Open
  • TTM Yield 1.00%
  • Turnover 45%

Morningstar’s Analysis FPHAX

Will FPHAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Fidelity ® Select Pharmaceuticals Port’s Process Pillar rating is Average, but a strong management team still helps this strategy retain its Morningstar Medalist Rating of Silver.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the second-cheapest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings FPHAX

  • Current Portfolio Date
  • Equity Holdings 55
  • Bond Holdings 1
  • Other Holdings 12
  • % Assets in Top 10 Holdings 73.6
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector
22.93
182,110,581
Healthcare
13.54
107,521,038
Healthcare
9.55
75,825,416
Healthcare
6.00
47,680,920
Healthcare
4.82
38,269,717
Healthcare
4.59
36,444,702
Healthcare
3.49
27,740,328
Healthcare
3.14
24,968,834
Healthcare
3.09
24,513,501
Healthcare
2.44
19,414,987
Healthcare